FDA comments on phase I clinical trials without vector biodistribution data.
Epstein
S
S
Bauer
S
S
Miller
A
A
Pilaro
A
A
Noguchi
P
P
D017321:Clinical Trials, Phase I as Topic / Q000331:legislation & jurisprudence*; D015316:Genetic Therapy / Q000009:adverse effects*; D005822:Genetic Vectors; D018095:Germ-Line Mutation; D006801:Humans; D016254:Mutagenesis, Insertional; D014018:Tissue Distribution; D014481:United States; D014486:United States Food and Drug Administration